Pediatric Liver Transplantation at UCLA

ADULT LIVER

LIVING DONORS

Meet Our Staff

Patient Information Brochures

TRUCK POWER BROCHUREOutpatient Case Manager's Educational Supplement for the Adult 
Liver Transplant Recipient


TRUCK POWER BROCHURELife After Transplantation: Taking Good Care of  Your New Liver

LIFE GOES ON TRUCK POWER BROCHURE

Medical Personnel Information Brochures

Primary Care Physician Management of the Adult Liver Transplant Recipient



Educational Modules

DIABETIC EDUCATION  for adult patients who are diabetic following Liver Transplant:
 
Truck Series I Kit: Installation Manual Module One - General Overview of Treatment and Safety
UX, Truck Series I, and Legend Series I Inverter/ChargersModule Two - Self Blood Sugar Monitoring
UX, Truck Series I, and Legend Series I Inverter/ChargersModule Three - Diet and Nutrition + Recipe/Meal Plan Supplement
UX, Truck Series I, and Legend Series I Inverter/ChargersModule Four - Patient Responsibilities
UX, Truck Series I, and Legend Series I Inverter/ChargersModule Five - Long Term Self Care


 

The Dumont-UCLA Pediatric Liver Transplant Program offers consultation, evaluation and treatment for children in liver failure who may require transplantation.

Program Experience

The Dumont-UCLA Pediatric Liver Transplant Program was established conjointly with the adult program in 1984. A cohesive team approach is utilized by pediatric gastroenterologists and liver transplant surgeons, with consultation from a full range of pediatric sub-specialties for post-transplant complications.

To date, over 500 pediatric transplants have been performed, making the program the largest of its kind in the world. Recently, the one-year survival rate has been 90 percent.

As a result of split-liver transplants, initiated in 1996, the waiting period for transplantation for children is often under 30 days. This time frame compares very favorably to the national average of 197 days for children under 1 year of age and 127 days for children 1 to 5 years old.

Program Approach

Biliary atresia is diagnosed in 50 to 75 percent of pediatric transplant recipients. Other indications for transplantation are fulminant liver disease and a wide range of metabolic diseases.

The evaluation for non-emergent transplantation is usually performed on an outpatient basis. Prior to evaluation, a telephone consultation with the referring physician is conducted.

A pediatric gastroenterologist and a transplant surgeon perform a full history and physical, including a medical record review. A lengthy conference with the family follows the evaluation.

If transplantation is imminent, a consultation with the program's nurse coordinator and social worker is arranged, either during the initial visit or as a second appointment.

Laboratory testing, including a comprehensive infectious disease screening, and an ultrasound are ordered. A liver biopsy is also performed occasionally.

Following evaluation and testing, transplant candidates are reviewed by the Transplant Evaluation Committee, made up of all team members, and a decision about listing for transplantation is made.

Three transplantation options exist: whole liver, split liver, or living related. The latter option is only considered if cadaveric livers are not available.

Split-liver transplants have greatly enhanced the utilization of donor organs. In these cases, a whole cadaveric liver is divided into two. Approximately one-third of the liver mass (the left lateral segment) is transplanted into a child, and the remaining two-thirds into an adult or large child. Once transplanted, the liver regenerates and grows with the recipient. UCLA is one of only six programs in the nation to offer split-liver transplants.

Post-transplant hospital care averages three weeks. During this time, the patient is managed by both the pediatric gastroenterologist and the transplant surgeon. Additionally, the Department of Pediatrics' Child Life Program plays a major role in rehabilitation.

Research Applications

Program research consists of clinical studies conducted in collaboration with the Division of Liver and Pancreas Transplantation and with other pediatric subspecialists.

The major research interest of faculty is immunosuppression in children. UCLA pioneered the first clinical trials for tacrolimus, a new drug option. Current research continues to actively investigate all aspects of tacrolimus.

Additionally, program faculty are engaged in clinical trials of a new form of cyclosporine called neoral.

Ongoing clinical studies are being conducted for steroid withdrawal in children, long-term renal function and growth issues, and hepatitis C.

Team Members

Ronald W. Busuttil, M.D., Ph.D.
Professor and Chief, Division of Liver and Pancreas Transplantation,
Director, The Dumont-UCLA Transplant Center

Sue V. McDiarmid, M.D.
Associate Professor, Division of Pediatric Gastroenterology
Director, The Dumont-UCLA Pediatric Liver Transplant Program

Marvin E. Ament, M.D.
Professor, Division of Pediatric Gastroenterology

Martin G. Martin, M.D.
Assistant Professor,
Division of Pediatric Gastroenterology

Jorge Vargas, M.D.
Professor, Division of Pediatric Gastroenterology

Douglas G. Farmer, M.D.
Assistant Professor,
Division of Liver and Pancreas Transplantation,
The Dumont-UCLA Transplant Center

Susan Edelstein, M.D.
Assistant Professor,
Division of Liver and Pancreas Transplantation,
The Dumont-UCLA Transplant Center

Indications for Referral

Any child suspected of needing a liver transplant may be referred to the Dumont-UCLA Pediatric Liver Transplant Program. Early referrals are encouraged.

Contact for Patient Referral

During Business Hours:
Dumont-UCLA Pediatric Liver Transplant Program
(310) 206-6134

After-hours Emergencies:

Pediatric gastroenterologist or liver transplant surgeon on call (310) 825-6301

 

The United Network for Organ Sharing (UNOS) provides a toll-free patient services lines to help transplant candidates, recipients, and family members understand organ allocation practices and  transplantation data. You may also call this number to discuss problems you may be experiencing with your transplant center or the transplantation system in general. The toll-free patient services line number is 1-888-894-6361


HOME    ·    TX RESOURCE LINKS   ·    OUR LOCATION   ·    CONTACT US  
 

UCLA Transplant Services· ©Copyright · 2007